Medicare Drug Price Negotiation
From Selection to Strategy: Navigating IPAY28
As manufacturers prepare for IPAY 2028 — and the first inclusion of Part B products — the Medicare Drug Price Negotiation Program continues to evolve. With MFPs now released for IPAY 2026 and landing any moment for IPAY 2027, what can we learn from CMS’s approach so far? And how should manufacturers adapt their strategy from the moment of selection through to the negotiation table?
In this session, a joint team of advisors from Verpora & Manatt Health will provide first-hand perspectives from supporting manufacturers through IPAY 2026 and 2027, and the early preparations now underway for IPAY 2028. Drake Reiter will also share insights from a US payer, including shifting strategies as a result of Medicare drug price negotiations.
Drawing on experience across negotiation strategy, legal and regulatory counsel, payer behaviour, government HTA, and human performance science, the panel will offer practical guidance for manufacturers newly selected — or expecting to be selected — in the next round.
This webinar is open exclusively to personnel under the direct employement of pharmaceutical manufacturers.
Join us live Thursday 11 December, 2025
0800 PT / 1100 ET / 1600 London
REGISTER NOW
Core themes to be covered:
How CMS’s approach is evolving — and what the 2026 and 2027 MFPs signal for 2028
From selection to strategy: what early preparation looks like for IPAY 2028
The role of Most Favored Nation (MFN) pricing pressures and their influence on negotiation outcomes
What changes with the inclusion of Part B medicines — from a payer and access perspective
Real-world payer responses to MFP pricing and formulary strategy shifts
By joining, you’ll walk away with:
A clearer understanding of what CMS prioritises — and how that’s changing
Practical advice on how to prepare from the moment of selection
Strategic guidance on positioning your value — clinically, economically, and organisationally
Insight into payer dynamics shaping access under MFP pricing
Lessons from those actively supporting manufacturers through the negotiation process
Format & Duration
1-hour fireside chat with a panel of professionals involved in previous and current IPAY negotiations.
Attendees will be invited to join our experts for a private Q&A follow-up session.
Who Should Attend?
This webinar is open exclusively to personnel from pharmaceutical manufacturers in the following functions will benefit from attending the webinar:
| Brand | Contract Operations | Contract Strategy |
| Corporate Communications | Government Affairs | Finance |
| Leadership | Legal | Managed Markets |
| Market Access | Pricing Operations | Real-world Evidence |
| Government Pricing | Marketing | Key Accounts |
Join us live Thursday 11 December, 2025
0800 PT / 1100 ET / 1600 London
REGISTER NOW
Speakers
Adam Bucker
VP Innovative Contracting, Verpora
& Webinar Chair
A global authority on value-based contracting, guiding clients from inception to implementation through the INSPIRE process.
LinkedIn
Chris Webber
Head of Negotiation, Verpora
20+ years advising pharmaceutical manufacturer negotiations with governments, health insurers, and PBMs both in the U.S. and globally.
LinkedIn
Omar Ali
Head of Payers, Verpora
Former Health Technology Assessment advisor to NICE with 25+ years experience supporting manufacturers in government and commercial negotiations both in the U.S. and globally.
LinkedIn
Ross Margulies
Partner, Manatt Health
Over 15 years of experience as a healthcare regulatory attorney, including extensive experience advising manufacturers on their engagements with CMS.
LinkedIn
Drake Reiter
Director, Pharmacy Operations, Priority Health
A leader in developing cross-functional strategy across pharmacy and medical benefits, bringing payer insights shaped by frontline experience in Medicare, formulary design, and value-based programs..
LinkedIn
Join us live Thursday 11 December, 2025
0800 PT / 1100 ET / 1600 London
REGISTER NOW
About Verpora
Verpora is a highly specialized consultancy in the field of innovative contracting and value-based pricing for the life sciences industry.
In a novel, first-of-its-kind approach, Verpora has pioneered the integration of human performance factors with payer behavior, data science and commercial negotiation strategy to deliver outcomes that are outstanding.
When healthcare innovations struggle to demonstrate their true value to stakeholders, Verpora’s team of experts leverage the relationship between people, data, and the systems in which they interact to optimize patient access and price for healthcare technologies.
About Manatt
Manatt is a multidisciplinary, integrated national professional services firm known for quality and an extraordinary commitment to clients. We are keenly focused on specific industry sectors, providing legal and consulting capabilities at the very highest levels to achieve our clients’ business objectives.
Our groundbreaking approach—bringing together legal services, advocacy and business strategy—differentiates us from our competitors and positions us to provide a unique and compelling value proposition. We strive to be essential to our clients.